having alpha [RSABE / ABEL]

posted by martin  – Austria, 2013-03-28 16:08 (4830 d 00:42 ago) – Posting: # 10304
Views: 30,996

Hi Helmut & simulants !

What do you think about a kind of adaptive group-sequential design with one interim analysis (i.e. estimate CV) allowing to make a decision regarding average BE or scaled BE in the final analysis? This may solve the problem.

best regards

martin

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
157 visitors (0 registered, 157 guests [including 15 identified bots]).
Forum time: 17:51 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5